rs2297902

Variant names:

Your query was ambiguous. Multiple possible variants found:

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000069.3(CACNA1S):c.2748C>T(p.His916His) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0199 in 1,608,184 control chromosomes in the GnomAD database, including 1,214 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 172 hom., cov: 32)

Exomes 𝑓: 0.020 ( 1042 hom. )

Consequence

CACNA1S
NM_000069.3 splice_region, synonymous

Scores

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.533

Publications

19 publications found

Variant links:

Genes affected

CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]

CACNA1S Gene-Disease associations (from GenCC):

hypokalemic periodic paralysis, type 1
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
malignant hyperthermia, susceptibility to, 5
Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
congenital myopathy 18
Inheritance: AR, AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
congenital myopathy
Inheritance: SD, AD, AR Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
hypokalemic periodic paralysis
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

CACNA1S links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.33).

BP6

Variant 1-201065943-G-A is Benign according to our data. Variant chr1-201065943-G-A is described in ClinVar as Benign. ClinVar VariationId is 254822.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=0.533 with no splicing effect.

BA1

GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.192 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000069.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	CACNA1S	NM_000069.3	MANE Select	c.2748C>T	p.His916His	splice_region synonymous	Exon 22 of 44	NP_000060.2	Q13698

Ensembl Transcripts

Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
CACNA1S	ENST00000362061.4	TSL:1 MANE Select	c.2748C>T	p.His916His	splice_region synonymous	Exon 22 of 44	ENSP00000355192.3	Q13698
CACNA1S	ENST00000367338.7	TSL:5	c.2748C>T	p.His916His	splice_region synonymous	Exon 22 of 43	ENSP00000356307.3	B1ALM3
CACNA1S	ENST00000681874.1		c.2688C>T	p.His896His	splice_region synonymous	Exon 21 of 43	ENSP00000505162.1	A0A7P0T8M7

Frequencies

GnomAD3 genomes

AF:

0.0230

AC:

3496

AN:

152172

Hom.:

162

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0109

Gnomad AMI

AF:

0.00110

Gnomad AMR

AF:

0.0352

Gnomad ASJ

AF:

0.0193

Gnomad EAS

AF:

0.202

Gnomad SAS

AF:

0.0319

Gnomad FIN

AF:

0.0367

Gnomad MID

AF:

0.0538

Gnomad NFE

AF:

0.0113

Gnomad OTH

AF:

0.0320

GnomAD2 exomes

AF:

0.0383

AC:

9443

AN:

246738

AF XY:

0.0362

show subpopulations

Gnomad AFR exome

AF:

0.0114

Gnomad AMR exome

AF:

0.0644

Gnomad ASJ exome

AF:

0.0195

Gnomad EAS exome

AF:

0.199

Gnomad FIN exome

AF:

0.0349

Gnomad NFE exome

AF:

0.0117

Gnomad OTH exome

AF:

0.0308

GnomAD4 exome

AF:

0.0196

AC:

28527

AN:

1455894

Hom.:

1042

Cov.:

AF XY:

0.0199

AC XY:

14400

AN XY:

724474

show subpopulations

African (AFR)

AF:

0.0109

AC:

364

AN:

33378

American (AMR)

AF:

0.0620

AC:

2750

AN:

44384

Ashkenazi Jewish (ASJ)

AF:

0.0207

AC:

539

AN:

26066

East Asian (EAS)

AF:

0.194

AC:

7667

AN:

39586

South Asian (SAS)

AF:

0.0349

AC:

2994

AN:

85818

European-Finnish (FIN)

AF:

0.0360

AC:

1917

AN:

53274

Middle Eastern (MID)

AF:

0.0398

AC:

229

AN:

5752

European-Non Finnish (NFE)

AF:

0.00951

AC:

10528

AN:

1107464

Other (OTH)

AF:

0.0256

AC:

1539

AN:

60172

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.493

Heterozygous variant carriers

1482

2964

4446

5928

7410

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Exome Hom

Variant carriers

546

1092

1638

2184

2730

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0232

AC:

3526

AN:

152290

Hom.:

172

Cov.:

AF XY:

0.0254

AC XY:

1889

AN XY:

74446

show subpopulations

African (AFR)

AF:

0.0110

AC:

459

AN:

41562

American (AMR)

AF:

0.0351

AC:

538

AN:

15308

Ashkenazi Jewish (ASJ)

AF:

0.0193

AC:

AN:

3466

East Asian (EAS)

AF:

0.202

AC:

1043

AN:

5164

South Asian (SAS)

AF:

0.0321

AC:

155

AN:

4830

European-Finnish (FIN)

AF:

0.0367

AC:

390

AN:

10614

Middle Eastern (MID)

AF:

0.0578

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.0113

AC:

767

AN:

68026

Other (OTH)

AF:

0.0421

AC:

AN:

2114

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.495

Heterozygous variant carriers

164

328

491

655

819

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

132

176

220

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.0183

Hom.:

155

Bravo

AF:

0.0255

Asia WGS

AF:

0.116

AC:

403

AN:

3478

ClinVar

ClinVar submissions

Significance:Benign

Revision:criteria provided, multiple submitters, no conflicts

View on ClinVar

Pathogenic

VUS

Benign

Condition

Malignant hyperthermia, susceptibility to, 5 (3)

not provided (3)

not specified (3)

Hypokalemic periodic paralysis, type 1 (2)

Congenital myopathy 18 (1)

Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 (1)

Thyrotoxic periodic paralysis, susceptibility to, 1 (1)

Computational scores

Source: dbNSFP v4.9

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.33

CADD

Benign

(source)

DANN

Benign

0.89

PhyloP100

0.53

Mutation Taster

=93/7

polymorphism (auto)

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.010

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Variant Effect in Transcripts

RefSeq Transcripts

Ensembl Transcripts

Frequencies

Age Distribution

Age Distribution

ClinVar

Computational scores

Splicing

Publications

Other links and lift over